VEERAIAH KARUMANCHI, MD
Child & Adolescent Psychiatry Physician in TUCSON, Arizona. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
VEERAIAH KARUMANCHI, MD reported a CMS MIPS final score of 61.8147/100 — below the 83.1 national average — and filed 660 Medicare Part D claims in 2023.
- 61.8147/100
- MIPS score · -21 vs avg
- 660
- Part D claims, 2023
- 98%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
VEERAIAH KARUMANCHI, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
62 6th percentile higher than 6% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
VEERAIAH KARUMANCHI, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about VEERAIAH KARUMANCHI, MD?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Arizona
How Child & Adolescent Psychiatry Physician compares to other specialties among Arizona providers
Child & Adolescent Psychiatry Physician share within Arizona
Child & Adolescent Psychiatry Physician is one of the more visible NUCC categories in Arizona
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
VEERAIAH KARUMANCHI, MD's 2023 MIPS final score plotted against the Child & Adolescent Psychiatry Physician national average
- MIPS Final Score
- 61.8147/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Child & Adolescent Psychiatry Physician) — 61.8147/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Child & Adolescent Psychiatry Physician US NPIs
61.8147/100 MIPS final score — 21.3 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Child & Adolescent Psychiatry Physician. Quality dim: 39.3823. Cost dim: 100.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
VEERAIAH KARUMANCHI, MD appears in the CMS NPPES registry as a Child & Adolescent Psychiatry Physician provider holding MD credentials at 502 W. 29TH STREET, TUCSON, AZ, 85713, with a listed phone of (520) 884-9920. NPI 1467456707 was issued on 06/01/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what KARUMANCHI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 660 prescription claims written by this provider, covering 134 Medicare beneficiaries and totaling roughly $44K in drug spend, split 2% brand-name and 98% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 61.8147/100 for the 2023 performance year (Quality 39.3823, Cost 100), compared with the national average of 83.1.
Child & Adolescent Psychiatry Physician is a mid-sized specialty nationwide, with 6,160 enrolled providers across 54 states and an average of 600 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1467456707 |
|---|---|
| Specialty | Child & Adolescent Psychiatry Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 06/01/2005 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm VEERAIAH KARUMANCHI, MD's current license status, disciplinary history, and board certifications with the Arizona Medical Board in Arizona before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Brand vs generic prescribing mix · Generic-heavy
2% brand-name claims vs 98% generic, on 660 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 666
- Total Day Supply
- 18,470
- Brand vs Generic
- 2% brand / 98% generic
- Brand Drug Cost
- $19K
- Generic Drug Cost
- $25K
Patient Demographics
- Average Patient Age
- 60.0 years
- Avg HCC Risk Score
- 1.67
- Gender Split
- 49% female / 51% male
- Age Distribution
- <65: 85, 65-74: 39, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What VEERAIAH KARUMANCHI, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Trazodone Hcl
Trazodone Hcl
75 claims
- Sertraline Hcl
Sertraline Hcl
65 claims
- Buspirone Hcl
Buspirone Hcl
60 claims
- Benztropine Mesylate
Benztropine Mesylate
38 claims
- Haloperidol 27
Haloperidol
27 claims
- Quetiapine Fumarate 26
Quetiapine Fumarate
26 claims
- Aripiprazole 24
Aripiprazole
24 claims
- Risperidone 24
Risperidone
24 claims
| Drug | Claims |
|---|---|
| Trazodone Hcl | 75 |
| Sertraline Hcl | 65 |
| Buspirone Hcl | 60 |
| Benztropine Mesylate | 38 |
| Haloperidol | 27 |
| Quetiapine Fumarate | 26 |
| Aripiprazole | 24 |
| Risperidone | 24 |
| Lamotrigine | 20 |
| Gabapentin | 19 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Child & Adolescent Psychiatry Physician Overview
How VEERAIAH KARUMANCHI, MD fits within the Child & Adolescent Psychiatry Physician landscape nationally.
VEERAIAH KARUMANCHI, MD's 660 claims are above the specialty average of 600.
Nearby Child & Adolescent Psychiatry Physician Providers in Arizona
Other clinicians with the same primary specialty enrolled in Arizona, drawn from the same CMS NPPES roster as KARUMANCHI.
Compare Child & Adolescent Psychiatry Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Arizona
Frequently Asked Questions
What is VEERAIAH KARUMANCHI, MD's specialty? ▼
How much does VEERAIAH KARUMANCHI, MD prescribe under Medicare Part D? ▼
What is VEERAIAH KARUMANCHI, MD's Medicare quality score? ▼
Where is VEERAIAH KARUMANCHI, MD located? ▼
What is VEERAIAH KARUMANCHI, MD's NPI number? ▼
Does VEERAIAH KARUMANCHI, MD prescribe more brand-name or generic drugs? ▼
How many Child & Adolescent Psychiatry Physician providers are there in the US? ▼
What drugs does VEERAIAH KARUMANCHI, MD prescribe most often? ▼
Does VEERAIAH KARUMANCHI, MD accept Medicare? ▼
How can I verify VEERAIAH KARUMANCHI, MD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology